Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden.
Centre for Clinical Research Sormland, Uppsala University, Eskilstuna, Sweden.
JAMA. 2020 Dec 22;324(24):2536-2547. doi: 10.1001/jama.2020.21360.
IMPORTANCE: Gastroesophageal reflux disease (GERD) is defined by recurrent and troublesome heartburn and regurgitation or GERD-specific complications and affects approximately 20% of the adult population in high-income countries. OBSERVATIONS: GERD can influence patients' health-related quality of life and is associated with an increased risk of esophagitis, esophageal strictures, Barrett esophagus, and esophageal adenocarcinoma. Obesity, tobacco smoking, and genetic predisposition increase the risk of developing GERD. Typical GERD symptoms are often sufficient to determine the diagnosis, but less common symptoms and signs, such as dysphagia and chronic cough, may occur. Patients with typical GERD symptoms can be medicated empirically with a proton pump inhibitor (PPI). Among patients who do not respond to such treatment or if the diagnosis is unclear, endoscopy, esophageal manometry, and esophageal pH monitoring are recommended. Patients with GERD symptoms combined with warning symptoms of malignancy (eg, dysphagia, weight loss, bleeding) and those with other main risk factors for esophageal adenocarcinoma, such as older age, male sex, and obesity, should undergo endoscopy. Lifestyle changes, medication, and surgery are the main treatment options for GERD. Weight loss and smoking cessation are often useful. Medication with a PPI is the most common treatment, and after initial full-dose therapy, which usually is omeprazole 20 mg once daily, the aim is to use the lowest effective dose. Observational studies have suggested several adverse effects after long-term PPI, but these findings need to be confirmed before influencing clinical decision making. Surgery with laparoscopic fundoplication is an invasive treatment alternative in select patients after thorough and objective assessments, particularly if they are young and healthy. Endoscopic and less invasive surgical techniques are emerging, which may reduce the use of long-term PPI and fundoplication, but the long-term safety and efficacy remain to be scientifically established. CONCLUSIONS AND RELEVANCE: The clinical management of GERD influences the lives of many individuals and is responsible for substantial consumption of health care and societal resources. Treatments include lifestyle modification, PPI medication, and laparoscopic fundoplication. New endoscopic and less invasive surgical procedures are evolving. PPI use remains the dominant treatment, but long-term therapy requires follow-up and reevaluation for potential adverse effects.
重要性:胃食管反流病(GERD)定义为反复出现的、令人困扰的烧心和反流,或 GERD 特异性并发症,影响约 20%的高收入国家的成年人口。
观察结果:GERD 可影响患者的健康相关生活质量,并与食管炎、食管狭窄、巴雷特食管和食管腺癌的风险增加相关。肥胖、吸烟和遗传易感性增加 GERD 的发病风险。典型的 GERD 症状通常足以确定诊断,但不太常见的症状和体征,如吞咽困难和慢性咳嗽,可能发生。有典型 GERD 症状的患者可以用质子泵抑制剂(PPI)进行经验性治疗。对于那些对这种治疗没有反应或诊断不明确的患者,建议进行内镜检查、食管测压和食管 pH 监测。有 GERD 症状并伴有恶性肿瘤的警告症状(如吞咽困难、体重减轻、出血)的患者,以及有其他食管腺癌主要危险因素(如年龄较大、男性和肥胖)的患者,应进行内镜检查。生活方式改变、药物治疗和手术是 GERD 的主要治疗选择。减肥和戒烟通常是有用的。用 PPI 进行药物治疗是最常见的治疗方法,在初始全剂量治疗后(通常为奥美拉唑 20mg 每日 1 次),目标是使用最低有效剂量。观察性研究表明,长期使用 PPI 后会出现几种不良反应,但这些发现需要在影响临床决策之前得到证实。在经过彻底和客观的评估后,腹腔镜胃底折叠术是一种有选择的侵袭性治疗方法,特别是对于年轻和健康的患者。内镜和较不侵袭性的手术技术正在出现,这可能会减少长期使用 PPI 和胃底折叠术,但长期的安全性和疗效仍有待科学确立。
结论和相关性:GERD 的临床管理影响着许多人的生活,并导致大量的医疗保健和社会资源消耗。治疗包括生活方式改变、PPI 药物治疗和腹腔镜胃底折叠术。新的内镜和较不侵袭性的手术程序正在不断发展。PPI 的使用仍然是主要的治疗方法,但长期治疗需要随访和重新评估潜在的不良反应。
JAMA. 2020-12-22
Clin Gastroenterol Hepatol. 2022-5
Prim Care. 2017-12
World J Gastroenterol. 2014-10-21
Front Public Health. 2025-8-6
Wien Klin Wochenschr. 2025-7-25
Clin Exp Pharmacol Physiol. 2025-8
Nutrients. 2025-5-8